Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment
Acta Dermato-Venereologica · 2025
DOI: 10.2340/actadv.v105.42840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Chuyen Thi Hong Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. chuyennguyen@ump.edu.vn. Hauptthemen laut MEDLINE: Psoriasis, Patient Preference, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Psoriasis is a chronic autoimmune disease that significantly impairs patients’ quality of life. With the growing availability of biologic drugs – each varying in efficacy, safety, dosing, and cost – treatment decisions have become increasingly complex. A study conducted from March to July 2024 surveyed 302 Vietnamese patients with moderate to severe psoriasis to assess preferences for biologic therapies. Using a discrete choice experiment (DCE), participants evaluated 6 treatment attributes: short-term efficacy, long-term efficacy, sustained efficacy after drug withdrawal, frequency of administration, copayment, and risk of serious infection. Preference data were analysed using conditional logit models. Analysis revealed that treatment cost (relative importance [RI]: 31.4%) and long-term efficacy (RI: 25.3%) were the most critical factors influencing patient decisions, while sustained efficacy after withdrawal and early onset of efficacy were less impactful. Long-term efficacy and cost consistently ranked highest across all patient subgroups, with variations depending on demographic and clinical characteristics. These findings provide practical guidance for clinicians to incorporate patient preferences into the selection of biologic therapies, with particular emphasis on treatment cost and long-term efficacy. The significant influence of treatment cost also highlights the need for healthcare policymakers in Vietnam to enhance reimbursement policies and financial support programmes, improving access and equity in psoriasis care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. chuyennguyen@ump.edu.vn.
- Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.
Zitieren
APA
Nguyen, C. T. H., Thi Mai Nguyen, X., & The Van, T. (2025). Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.42840
Vancouver
Nguyen CTH, Thi Mai Nguyen X, The Van T. Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.42840
BibTeX
@article{Nguyen2025,
author = {Nguyen, Chuyen Thi Hong and Thi Mai Nguyen, Xuan and The Van, Trung},
title = {Patient-centred Preferences for Biologic Therapies in Moderate to Severe Psoriasis in Vietnam: A Discrete Choice Experiment},
journal = {Acta Dermato-Venereologica},
year = {2025},
doi = {10.2340/actadv.v105.42840}
}
EUVIMED